These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28573754)

  • 1. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
    J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
    Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
    J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S; Green D; Christley R; Dukes-McEwan J
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
    Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
    Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
    Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
    J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced electrocardiographic parameters change with severity of mitral regurgitation in Cavalier King Charles Spaniels in sinus rhythm.
    Spiljak Pakkanen M; Domanjko Petrič A; Olsen LH; Stepančič A; Schlegel TT; Falk T; Rasmussen CE; Starc V
    J Vet Intern Med; 2012; 26(1):93-100. PubMed ID: 22168834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
    Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
    J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of natriuretic peptides in dogs with mitral valve disease.
    Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
    Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    Ghilardi S; Lecchi C; Bagardi M; Romito G; Colombo FM; Polli M; Franco C; Brambilla PG
    PLoS One; 2022; 17(12):e0274724. PubMed ID: 36574372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
    Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
    Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.
    Sargent J; Muzzi R; Mukherjee R; Somarathne S; Schranz K; Stephenson H; Connolly D; Brodbelt D; Fuentes VL
    J Vet Cardiol; 2015 Mar; 17(1):1-12. PubMed ID: 25586168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
    J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Olsson K
    Am J Vet Res; 1994 May; 55(5):698-703. PubMed ID: 8067620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.
    Hezzell MJ; Boswood A; Moonarmart W; Elliott J
    J Vet Cardiol; 2012 Mar; 14(1):269-79. PubMed ID: 22366569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between syringomyelia and myxomatous mitral valve disease in Cavalier King Charles spaniels.
    Bach MBT; Stougaard CL; Thøfner MS; Reimann MJ; Westrup U; Koch J; Fredholm M; Martinussen T; Berendt M; Olsen LH
    J Vet Intern Med; 2024; 38(2):904-912. PubMed ID: 38391152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of selected one-, two- and three-dimensional and Doppler echocardiographic methods to assess severity in dogs with myxomatous mitral valve disease.
    Tidholm A; Häggström J
    J Vet Cardiol; 2022 Feb; 39():89-101. PubMed ID: 35008002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
    Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.